Fig. 1From: Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patientsWaterfall plot of tumor burden change at best overall response in 56 patients. Two patients marked by * had greater than 200% (+219% and +278%). Dashed lines represent the thresholds for partial response (−30%) and progressive disease (+20%)Back to article page